Servier India introduces ‘Ivosidenib’(Tibsovo®)

Mumbai (Maharashtra) [India], June 5: Servier India, a subsidiary of the leading French pharmaceutical Servier...

Immune cells found to boost cancer treatment in AML: Study 

A research team from Columbia Engineering and the Irving Institute for Cancer Dynamics achieved a significant...

Urgent Appeal To Support Sonia Sood Fight Against Leukemia

Chandigarh (Punjab) [India], November 6: In a heart-wrenching plea for help, Yamini Sood is urgently seeking...

BD India Initiated Workshop aims to achieve consensus

New Delhi [India], June 16: To achieve a consensus on a suitable panel and analysis strategy to report Acute Myeloid...

Researchers find new vulnerability of acute myeloid leukemia

Acute myeloid leukaemia (AML) is a blood cancer that causes an uncontrollable buildup of white blood cells. Due to...

Study suggests risk of leukemia higher in children with Down...

Washington [US], April 7 (ANI): A new study highlighted the risks of leukemia in children with Down syndrome. It...

Study reveals new drug therapy for leukemia patients

Washington [US], February 20 (ANI): A clinical study by the scientists of McMaster University claims to have taken...

Large Gene panel helpful in identifying cancer-causing genes

Washington [US], February 6 (ANI): Researchers during a recent study have found a gene panel that includes all genes...

Panel finds more gene mutations, treatment targets for leukemia

Washington [US], February 1 (ANI): A gene panel that looks for about 10 times the number of cancer-causing genes as...

Study introduces new drug combination as ground-breaking...

California [US], January 19 (ANI): A collaborative study by scientists of Sanford Burnham Prebys Medical Discovery...

Combination therapy to improve survival outcomes in certain...

Houston [United States], August 16 (ANI): According to a recent study, a combination regimen of venetoclax and...

Combination therapy improves survival outcomes in certain...

Houston [United States], August 13 (ANI): A combination regimen of venetoclax and azacitidine was safe and improved...